HRT for Menopause: Pros, Cons, Types and How to Decide

If you have heard that HRT is dangerous, and then heard it described as life-changing, you are not imagining the mixed messages. The truth is more useful than either extreme: HRT can be highly effective for menopause symptoms, but whether it suits you depends on your age, health history, symptoms, preferences and the type of treatment used.

This guide explains HRT for menopause pros and cons in plain English: what the hormones do, how patches, gels and tablets differ, what “body-identical” really means, how thinking on risk has changed, and who may need a different approach. It ends with a worksheet to help you weigh it up before you speak to a clinician.

Medical note: this article is general information, not personal medical advice. Decisions about HRT should be made with a doctor, nurse practitioner, menopause specialist or other qualified healthcare professional who knows your medical history.

What HRT actually is (and what it isn’t)

HRT stands for hormone replacement therapy. In the US and Australia you will often see it called MHT (menopausal hormone therapy) or simply HT. These terms describe the same broad treatment: hormones used to relieve symptoms of perimenopause and menopause. We use HRT throughout.

The main hormone in HRT is estrogen. Estrogen levels fluctuate during perimenopause and fall after menopause, which can contribute to hot flushes, night sweats, disrupted sleep, vaginal dryness, urinary symptoms, mood changes and joint aches.

If you still have a uterus, you will usually also need a progestogen. Its job is not mainly symptom relief. It protects the lining of the womb, because estrogen on its own can make that lining build up and increase the risk of endometrial (womb) cancer.

A simple way to remember it: estrogen does most of the symptom work; progestogen provides womb-lining protection.

Women who have had a hysterectomy often take estrogen alone, although there are exceptions, such as some women with a history of endometriosis. Your clinician can advise based on your surgery and history.

Two things HRT is not: it is not contraception, so if you are in perimenopause and could still become pregnant, ask about contraception separately. And it is not an anti-ageing or weight-loss treatment.

The building blocks: estrogen, progestogen and where testosterone fits

Estrogen: the symptom-relief hormone

Many modern prescriptions use estradiol, which is chemically identical to the main estrogen made by the ovaries before menopause. Other preparations, such as conjugated estrogens, are still used in some countries, particularly the US.

Estrogen can be absorbed through the skin (patch, gel or spray), taken as a tablet, or used locally in the vagina as a cream, pessary, vaginal tablet, ring or gel.

Progestogen: the protection hormone

Progestogen is an umbrella term. Options include micronized progesterone, which is body-identical, and synthetic progestins such as norethisterone, medroxyprogesterone acetate and levonorgestrel. Dydrogesterone is used in some countries.

Some women use a levonorgestrel-releasing intrauterine system, often called a hormonal coil, as the progestogen part of HRT. Licensing for this use differs by country, so confirm it with your clinician.

The type of progestogen matters. Side effects such as bloating or low mood can vary between types, and research suggests the breast cancer risk picture may differ too, as explained below.

Cyclical versus continuous HRT

• Cyclical (sequential) HRT usually means estrogen every day with progestogen for part of the month. It typically causes a regular, period-like bleed and is commonly used in perimenopause or soon after periods stop.
• Continuous combined HRT gives both hormones every day. It is usually used once you are postmenopausal, and is designed to be bleed-free once your body settles.

For example, a 47-year-old with irregular periods might be offered a cyclical pattern, while a 54-year-old whose periods stopped three years ago might be offered continuous combined HRT. Some spotting is common in the first months, but persistent, heavy or new bleeding should always be checked.

Where testosterone fits

Testosterone often comes up in menopause conversations online. It is not part of standard HRT. Some guidelines support considering it for low sexual desire that causes distress and has not improved with estrogen-based HRT. Licensing and availability vary considerably by country, so it is a specialist conversation rather than a first step.

Patches, gels, sprays, tablets and local estrogen: how they compare

Here is the quick version before the detail:

• Patch: stuck to the skin and changed once or twice a week. Pros: steady dosing, no daily routine, not linked to the raised clot risk seen with tablets. Cons: skin irritation, can lift with sweat or swimming.
• Gel or spray: applied to the skin daily. Pros: easy to adjust the dose, not linked to the raised clot risk seen with tablets. Cons: drying time, and gel can transfer to others through skin contact before it dries.
• Tablet: swallowed daily. Pros: familiar, simple, available as combined estrogen-and-progestogen pills. Cons: a small increased risk of blood clots and stroke.
• Local vaginal estrogen: cream, pessary, vaginal tablet, ring or gel. Pros: targets vaginal and urinary symptoms at a low dose with minimal absorption. Cons: does not treat hot flushes or night sweats.

Through the skin: patches, gels and sprays

Transdermal estrogen enters the bloodstream without first passing through the liver, which is one reason its risk profile differs from tablets. Guidance from bodies including NICE, the British Menopause Society, The Menopause Society and the Australasian Menopause Society recognises it as a useful option, particularly for women with certain clotting, migraine or cardiovascular risk factors.

A typical gel routine: apply after a morning shower, let it dry fully, then dress. Exact sites and amounts depend on the product instructions.

Tablets

Tablets suit many women and can simplify routines. The trade-off is that oral estrogen is linked with a small increased risk of blood clots and stroke. For healthy women under 60 the absolute risk remains low, but route matters. A clinician may suggest a patch or gel instead if you have migraine with aura, a higher clot risk, a raised BMI, smoke, or have other risk factors.

Local vaginal estrogen

Local estrogen treats genitourinary syndrome of menopause: vaginal dryness, irritation, painful sex and some recurrent urinary symptoms. At standard doses, it is generally not considered to need a progestogen for womb protection, and it is often used long term.

Someone who sleeps well and has no flushes but finds sex painful may not need full-body HRT at all. Local treatment alone may be enough. Others use it alongside systemic HRT.

Other options

Tibolone (not available in the US) and a combination of conjugated estrogens with bazedoxifene are used in some countries. Availability varies, so ask locally.

Body-identical, bioidentical and synthetic: what the words mean

The language around “natural” hormones is confusing, and sometimes deliberately so.

Body-identical HRT usually means regulated, licensed estradiol and micronized progesterone. They are structurally the same as hormones made by the body and are manufactured and tested to approved standards.

Compounded bioidentical hormones are custom-mixed by some private clinics or pharmacies. Major menopause and gynaecology organisations advise against them because they are not regulated, tested or quality-controlled in the same way as licensed medicines, and doses can vary from batch to batch.

Synthetic does not automatically mean bad. Synthetic progestins have long track records, and the hormonal coil is a practical form of womb protection for many women.

Be wary of marketing that uses phrases like:

• “custom-made” or “tailored to your unique hormones”
• “natural, so no risks”
• “saliva testing to balance your hormones”
• claims that compounded products are safer than licensed HRT

What HRT can help with

For most women, HRT is the most effective treatment available for hot flushes and night sweats. When those ease, sleep often improves, with knock-on effects on energy, mood and concentration.

• hot flushes and night sweats
• sleep disrupted by night sweats
• vaginal dryness and painful sex
• some menopause-related urinary symptoms
• bone density, with reduced fracture risk while it is being taken
• menopause-related mood swings and irritability for many women
• joint and muscle aches for some women, although evidence here is less clear

It is important not to oversell it. HRT is not prescribed to prevent heart disease or dementia. It is not a treatment for clinical depression, although it may be part of a wider conversation about mood.

Many women notice improvement within weeks, but it commonly takes around three months to judge the full effect. Adjusting the dose, route or progestogen is normal and does not mean HRT has failed.

The risks, in context

Risk depends on the person and the prescription: your age, time since menopause, personal and family history, whether you take estrogen alone or combined HRT, the type of progestogen, the dose and the route.

Why thinking changed after 2002

Much of the fear around HRT stems from the Women’s Health Initiative study, first reported in 2002, after which many women stopped treatment. Later analyses added important context: participants were on average older and further past menopause than most women who seek HRT for symptoms, and the study used specific oral preparations.

Today, major guideline bodies say that for many healthy women who start HRT before 60 or within about ten years of menopause, the benefits for symptom relief often outweigh the risks. That is not the same as “no risk”. It means the balance is often more favourable than early headlines suggested.

Breast cancer

Combined HRT (estrogen plus progestogen) is associated with a small increased risk of breast cancer that tends to rise with longer use and falls after stopping.

Estrogen-only HRT has a different profile. Clinical trial data, including from the Women’s Health Initiative, and current UK guidance indicate little or no change in breast cancer risk. Some large observational studies suggest a smaller increase than with combined HRT, particularly with longer use, so duration and personal risk should still be reviewed.

Some observational evidence suggests micronized progesterone or dydrogesterone may carry a lower associated risk than some synthetic progestins, but this is still being studied. Guideline bodies often put the overall risk in context alongside other factors, such as regular alcohol intake or carrying excess weight. Your family history and any previous breast investigations belong in the conversation.

Blood clots and stroke

Oral estrogen is associated with a small increased risk of blood clots and stroke. Transdermal estrogen at standard doses does not appear to increase clot risk in the same way.

Womb cancer

If you have a uterus, taking systemic estrogen without adequate progestogen increases the risk of womb cancer. That is why the progestogen part of HRT is not optional unless your clinician has a specific reason.

Heart health and other considerations

Starting HRT more than ten years after menopause or after 60 may carry more cardiovascular risk than starting earlier. Oral estrogen is also associated with gallbladder disease.

Common side effects

Early side effects can include breast tenderness, bloating, headaches, nausea, mood changes and irregular bleeding. These often settle within a few months, and a different dose, route or progestogen may help if they don’t.

The risks of not treating

Declining HRT is a valid choice, but untreated symptoms can affect sleep, work, relationships and quality of life, and bone loss after menopause is a real consideration. These belong in the weighing-up too.

Who may not be a good candidate

HRT is usually not recommended, or needs specialist input, if you have:

• current or previous breast cancer or another hormone-sensitive cancer
• unexplained vaginal bleeding that has not been investigated
• a current or recent blood clot, heart attack or stroke
• active liver disease
• untreated high blood pressure
• a known high inherited cancer risk, such as a BRCA variant

Other conditions don’t automatically rule HRT out but shape the safest choice of route and type. These include migraine (especially with aura), diabetes, smoking, a raised BMI, endometriosis and a family history of clotting disorders. For example, a clinician might consider a steady-dose transdermal route for a woman with migraine with aura, but that is an individual decision, not a rule.

If HRT isn’t right for you, alternatives exist. Depending on your symptoms and where you live, these may include newer non-hormonal prescription medicines for hot flushes (approved in some countries), certain antidepressants and other prescription options, cognitive behavioural therapy for menopause symptoms, vaginal moisturisers and lubricants, and lifestyle changes that support sleep, bone and heart health.

HRT for menopause pros and cons: your personal worksheet

Use this as a thinking tool before an appointment. Print it or screenshot it. It is not a self-diagnosis checklist, and it does not replace advice from a qualified clinician.

1. Rate your symptoms

Score each from 0 (not a problem) to 5 (severely affecting life): hot flushes, night sweats, sleep, mood or irritability, brain fog, joint or muscle aches, vaginal dryness or painful sex, urinary symptoms, libido.

Then finish this sentence: “The biggest way menopause is affecting my life is…”

2. Note your health history

• your age, and when your periods changed or stopped
• whether you have a uterus
• personal or family history of breast, ovarian or womb cancer
• blood clots, stroke, heart disease or migraine (and which type)
• blood pressure, smoking, diabetes or liver disease
• bone health, fractures or early menopause
• current medicines and supplements

3. Clarify your preferences

• Patch, gel, spray or tablet?
• Daily application, or twice-weekly?
• How would I feel about a monthly bleed?
• Would I consider a hormonal coil?
• What are my cost, insurance or access concerns?

4. Name your values and worries

What matters most right now: symptom relief, long-term bone health, keeping any added cancer risk as low as possible, avoiding daily medication, or something else? Which risk worries you most, and why?

5. Draw your two columns

On one side, write “Potential benefits for me”. On the other, “Risks or inconveniences to weigh”. Fill them in using your answers above.

Illustrative example: imagine a 51-year-old with severe night sweats, poor sleep and a mother who had breast cancer after 70.

Potential benefits for me: better sleep; fewer night sweats disrupting work; protecting bone density.

Risks or inconveniences to weigh: a possible small rise in breast cancer risk with combined HRT; early side effects such as breast tenderness; remembering a daily gel.

Her question might be: “My main goal is sleep, and my main worry is breast cancer. Can we talk through my personal risk and which estrogen route and progestogen would make sense for me?” This doesn’t decide the answer. It makes the conversation more focused.

6. Questions to bring

• Given my history, would transdermal estrogen be better for me than tablets?
• Which progestogen would you suggest, and why?
• Would local vaginal estrogen help my symptoms?
• How soon should I expect improvement?
• When will we review this, and what would make us change the dose or type?
• How will we decide how long I stay on it?

Starting, reviewing and stopping

Many clinicians start at a low-to-moderate dose and review after around three months, then usually at least yearly, or sooner if symptoms, bleeding or your health change.

There is no universal time limit. Some women use HRT for a few years; others continue longer after reviewing benefits and risks. Stopping can be gradual or abrupt. Symptoms may return either way, and the evidence on which approach is better is mixed.

If you have premature ovarian insufficiency (menopause before 40) or early menopause (between 40 and 45), the picture is different. Guidelines widely advise hormone therapy at least until the average age of natural menopause, around 51, to help protect bone and heart health, unless there is a medical reason not to.

Costs and access vary. In England, an HRT prescription prepayment certificate can reduce costs for many HRT products; elsewhere, coverage depends on your insurance or public health scheme, so check locally.

FAQ

Does HRT cause weight gain?

Evidence does not show that HRT itself causes weight gain. Many women notice weight or body-shape changes in midlife due to ageing, hormonal shifts, poor sleep and stress, with or without HRT. Some women feel bloated in the first few months, which can feel like weight gain.

Can I use HRT if I am still having periods?

Yes. Many women start HRT in perimenopause, usually on a cyclical regimen chosen around their bleeding pattern. HRT does not prevent pregnancy, so ask separately about contraception.

Is it too late to start HRT after 60?

Not always, but the balance of benefits and risks shifts with age and time since menopause. Starting systemic HRT after 60, or more than about ten years after menopause, usually needs a more cautious, individual discussion. Local vaginal estrogen may still be suitable for many women.

Are compounded bioidentical hormones safer?

There is no good evidence that they are. Regulated body-identical options, such as licensed estradiol and micronized progesterone, already exist and are the ones guideline bodies support.

The bottom line

HRT is an effective, well-studied treatment with real but generally small risks for healthy women who start it within the usual timing window. The details matter: the route of estrogen, the type of progestogen, your age and your personal history.

When weighing HRT for menopause pros and cons, the useful question is not “Is HRT good or bad?” but “Which option, if any, fits my symptoms, my health and my priorities?” Choosing HRT can be a sound decision. Choosing not to can be sound too. Bring your worksheet, ask your questions, and make the decision with a qualified clinician as an informed partner in your own care.